India's Sun shares fall after report about U.S. FDA queries

MUMBAI (Reuters) - Shares of Sun Pharmaceutical Industries Ltd fell as much as 2.1 percent after Bloomberg News reported the drug maker had received queries from the U.S. Food and Drug Administration over quality control at a U.S. subsidiary. Sun received two so-called Form 483s, issued when the U.S. regulator has queries, for its Detroit-based Caraco Pharmaceutical Laboratories Ltd following inspections in January and May this year, Bloomberg reported on Monday, citing a Freedom of Information Act request. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/indias-sun-shares-fall-report-u-fda-queries-102130867--finance.html